Issue 5, 2013

Radiosynthesis and characterization of astemizole derivatives as lead compounds toward PET imaging of τ-pathology

Abstract

Formation of neurofibrillary tangles, comprising of microtubule-associated tau protein, is a hallmark of a group of neurodegenerative diseases, including Alzheimer's disease. In consequence, in vivo imaging of neurofibrillary tangles is a current focus of positron emission tomography research. Herein, development of an in vitro radioligand binding assay which uses synthetic aggregates as a model of neurofibrillary tangles is reported, together with evaluation of novel derivatives of the tau protein ligand astemizole.

Graphical abstract: Radiosynthesis and characterization of astemizole derivatives as lead compounds toward PET imaging of τ-pathology

Supplementary files

Article information

Article type
Concise Article
Submitted
14 Jan 2013
Accepted
13 Mar 2013
First published
14 Mar 2013

Med. Chem. Commun., 2013,4, 852-855

Radiosynthesis and characterization of astemizole derivatives as lead compounds toward PET imaging of τ-pathology

P. J. Riss, L. Brichard, V. Ferrari, D. J. Williamson, T. D. Fryer, Y. T. Hong, J. Baron and F. I. Aigbirhio, Med. Chem. Commun., 2013, 4, 852 DOI: 10.1039/C3MD00017F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements